Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Persicaria tinctoria* (also known as *Polygonum tinctorium*) is a medicinal plant and natural dye source belonging to the Polygonaceae family. Traditionally used in Southeast Asian medicine, it contains bioactive compounds such as indigo, indirubin, tryptanthrin, and various flavonol glycosides. Research indicates that extracts of the plant possess potent anti-inflammatory, antioxidant, and antimicrobial properties. It is primarily investigated for the treatment of inflammatory conditions like ulcerative colitis, atopic dermatitis, and psoriasis, as well as for its potential in bone metabolism (periodontal disease) and oncology. Its mechanism involves the suppression of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) and the inhibition of the NF-κB and MAPK signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on persicaria tinctoria.